DELAYING TRANSPLANTATION AFTER TOTAL BODY IRRADIATION IS A SIMPLE AND EFFECTIVE WAY TO REDUCE ACUTE GRAFT-VERSUS-HOST DISEASE MORTALITY AFTER MAJOR H2 INCOMPATIBLE TRANSPLANTATION1
- 1 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 64 (2) , 297-302
- https://doi.org/10.1097/00007890-199707270-00021
Abstract
We have previously reported that delaying histoincompatible transplantation after total body irradiation (TBI) conditioning markedly decreased the mortality of acute graft-versus-host disease (GVHD) in severe combined immunodeficiency mice. However, it was not clear whether the delayed transplantation would affect the final engraftment and acute GVHD mortality in normal hosts. BALB/c mice (H2d) were lethally irradiated with 8.5 Gy TBI and transplanted with C57BL/6 (H2d) bone marrow plus spleen cells on the same day (TBI+day 0) or 4 days after TBI conditioning (TBI+day 4). We again demonstrated that delaying transplantation by 4 days after TBI conditioning markedly reduced acute GVHD mortality in normal hosts after major histoincompatible transplantation. The survival rates were 66% in TBI+day 4 vs. 0% in TBI+day 0 allogeneic transplanted animals by day +60 (P. This 2- to 3-month early mixed chimerism in TBI+day 4 transplanted animals might be related to lower levels of tumor necrosis factor-α and IL-6 both of which have been shown to stimulate lymphohematopoiesis and was associated with lower acute GVHD mortality. The data again demonstrated in immunologically normal BALB/c mice that delaying allogeneic transplantation after TBI is a simple and effective way to reduce acute GVHD mortality, achieve satisfactory engraftment and significantly increase overall survival.Keywords
This publication has 13 references indexed in Scilit:
- SERUM LEVELS OF CYTOKINES AND SECONDARY MESSAGES AFTER T-CELL-DEPLETED AND NON-T-CELL-DEPLETED BONE MARROW TRANSPLANTATIONTransplantation, 1996
- THE EFFECT OF HUMAN IL-2-ACTIVATED NATURAL KILLER AND T CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA IN SCID MICE BEARING HUMAN LEUKEMIC CELLSTransplantation, 1995
- Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)Blood, 1995
- Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID miceBlood, 1994
- Cytokine dysregulation and acute graft-versus-host diseaseBlood, 1992
- Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development.The Journal of Experimental Medicine, 1992
- Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]Blood, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- The biology of interleukin-6Blood, 1989
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989